IL6 and neoplasm: After binding to its receptor, IL-6 triggers both the nuclear factor κB (NF-κB) cascade and STAT3 pathway, which are responsible for cell survival/tumor initiation and cell proliferation/tumor growth downstream, respectively28, 29.